New FDA Guidance on Artificial Intelligence Will Help MRDC Field Better Drugs More Quickly

As drug developers rely increasingly on artificial intelligence to assist with the discovery, testing and manufacture of new medicines, researchers at the Defense Health Agency Research and Development-Medical Research and Development Command are learning how to apply the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines that protect our Warfighters and enable them to maintain operational effectiveness even in chemically and biologically contaminated environments.

🔐 Securing GenAI Workloads: Protecting AI in Containers

This article focuses on security measures for GenAI workloads running in containers. It advocates for a lifecycle approach to security using tools and practices that cover deployment, orchestration, and monitoring. This is crucial as AI applications proliferate in major industries across multiple countries, enhancing vulnerability to attacks.

Read More: